wwwPosted Apr 16th 2008 2:31PM by Paul Foster
Filed under: Options
POZEN Inc. (NASDAQ: POZN) recently up $3.62 to $14.15 in pre-open trading:
The FDA granted marketing approval for POZN's Treximet (treatment for migraines). Smith Barney increased its price target on POZN to $19. POZN over all option implied volatility of 130 was above its 26-week average of 89 according to Track Data, suggesting large price movement.
Options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
| # | Blogger | Posts | Cmts |
|---|---|---|---|
| 1 | Joseph Lazzaro | 107 | 0 |
| 2 | Tom Johansmeyer | 97 | 3 |
| 3 | Connie Madon | 50 | 0 |
| 4 | Steven Mallas | 42 | 0 |
| 5 | Mark Fightmaster | 41 | 0 |
| 6 | Tom Taulli | 40 | 0 |
| 7 | Steven Halpern | 31 | 0 |
| 8 | Trey Thoelcke | 29 | 0 |
| 9 | Melly Alazraki | 25 | 0 |
| 10 | Zac Bissonnette | 23 | 0 |
| 11 | Paul Foster | 23 | 0 |
| 12 | Brian White | 22 | 0 |
| 13 | Brent Archer | 21 | 0 |
| 14 | Jon Ogg | 21 | 0 |
| 15 | Jim Cramer | 21 | 0 |
| 16 | Elizabeth Harrow | 18 | 0 |
| 17 | Eric Buscemi | 17 | 0 |
| 18 | Sheldon Liber | 13 | 0 |
| 19 | Michael Fowlkes | 8 | 0 |
| 20 | Beth Gaston Moon | 8 | 0 |
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
Other Weblogs Inc. Network blogs you might be interested in:
Will Rich Ross really have a positive impact on Disney's movie operations?
Consumers sick of recession, may spend extra on holidays
Corrections, seasonality and Santa Claus
Reader Comments (Page 1 of 1)
4-17-2008 @ 9:13AM
Atauber said...
Does anyone know howmuch %6 from GLK mean to POZN?